Similarity Score |
Similarity Level |
Drug ID |
Developmental Stage |
0.7746 |
Intermediate Similarity |
NPD7008 |
Discontinued |
0.7746 |
Intermediate Similarity |
NPD5952 |
Clinical (unspecified phase) |
0.7733 |
Intermediate Similarity |
NPD7236 |
Approved |
0.76 |
Intermediate Similarity |
NPD8166 |
Discontinued |
0.7597 |
Intermediate Similarity |
NPD7239 |
Suspended |
0.7536 |
Intermediate Similarity |
NPD3412 |
Clinical (unspecified phase) |
0.7515 |
Intermediate Similarity |
NPD8424 |
Clinical (unspecified phase) |
0.75 |
Intermediate Similarity |
NPD7799 |
Discontinued |
0.7471 |
Intermediate Similarity |
NPD8485 |
Approved |
0.7455 |
Intermediate Similarity |
NPD8470 |
Clinical (unspecified phase) |
0.7444 |
Intermediate Similarity |
NPD2181 |
Clinical (unspecified phase) |
0.7427 |
Intermediate Similarity |
NPD8435 |
Approved |
0.7427 |
Intermediate Similarity |
NPD8361 |
Approved |
0.7427 |
Intermediate Similarity |
NPD8360 |
Approved |
0.7425 |
Intermediate Similarity |
NPD8368 |
Discontinued |
0.7424 |
Intermediate Similarity |
NPD2182 |
Approved |
0.74 |
Intermediate Similarity |
NPD7702 |
Clinical (unspecified phase) |
0.7397 |
Intermediate Similarity |
NPD7961 |
Discontinued |
0.7345 |
Intermediate Similarity |
NPD8486 |
Clinical (unspecified phase) |
0.7333 |
Intermediate Similarity |
NPD6858 |
Approved |
0.7333 |
Intermediate Similarity |
NPD7094 |
Approved |
0.7325 |
Intermediate Similarity |
NPD7458 |
Discontinued |
0.731 |
Intermediate Similarity |
NPD8434 |
Phase 2 |
0.7305 |
Intermediate Similarity |
NPD6287 |
Discontinued |
0.7294 |
Intermediate Similarity |
NPD8407 |
Phase 2 |
0.7286 |
Intermediate Similarity |
NPD7163 |
Clinical (unspecified phase) |
0.7279 |
Intermediate Similarity |
NPD7713 |
Phase 3 |
0.7255 |
Intermediate Similarity |
NPD7003 |
Approved |
0.7255 |
Intermediate Similarity |
NPD4628 |
Phase 3 |
0.7244 |
Intermediate Similarity |
NPD6273 |
Approved |
0.7235 |
Intermediate Similarity |
NPD8313 |
Approved |
0.7235 |
Intermediate Similarity |
NPD8312 |
Approved |
0.7234 |
Intermediate Similarity |
NPD7457 |
Clinical (unspecified phase) |
0.7226 |
Intermediate Similarity |
NPD5951 |
Approved |
0.7225 |
Intermediate Similarity |
NPD8397 |
Clinical (unspecified phase) |
0.7211 |
Intermediate Similarity |
NPD3764 |
Approved |
0.7195 |
Intermediate Similarity |
NPD8127 |
Discontinued |
0.716 |
Intermediate Similarity |
NPD7058 |
Phase 2 |
0.716 |
Intermediate Similarity |
NPD7057 |
Phase 3 |
0.7121 |
Intermediate Similarity |
NPD164 |
Approved |
0.711 |
Intermediate Similarity |
NPD8150 |
Discontinued |
0.7101 |
Intermediate Similarity |
NPD2629 |
Approved |
0.7077 |
Intermediate Similarity |
NPD1238 |
Approved |
0.705 |
Intermediate Similarity |
NPD4198 |
Discontinued |
0.7037 |
Intermediate Similarity |
NPD6831 |
Clinical (unspecified phase) |
0.7007 |
Intermediate Similarity |
NPD1609 |
Clinical (unspecified phase) |
0.6968 |
Remote Similarity |
NPD7421 |
Clinical (unspecified phase) |
0.6949 |
Remote Similarity |
NPD7879 |
Clinical (unspecified phase) |
0.6947 |
Remote Similarity |
NPD7798 |
Approved |
0.6939 |
Remote Similarity |
NPD6007 |
Clinical (unspecified phase) |
0.6933 |
Remote Similarity |
NPD7819 |
Suspended |
0.6933 |
Remote Similarity |
NPD8455 |
Phase 2 |
0.6933 |
Remote Similarity |
NPD8032 |
Phase 2 |
0.6928 |
Remote Similarity |
NPD3748 |
Approved |
0.6923 |
Remote Similarity |
NPD7473 |
Discontinued |
0.6894 |
Remote Similarity |
NPD3226 |
Approved |
0.6883 |
Remote Similarity |
NPD2438 |
Suspended |
0.6875 |
Remote Similarity |
NPD6980 |
Clinical (unspecified phase) |
0.6861 |
Remote Similarity |
NPD2067 |
Discontinued |
0.6857 |
Remote Similarity |
NPD8055 |
Clinical (unspecified phase) |
0.6848 |
Remote Similarity |
NPD4868 |
Clinical (unspecified phase) |
0.6848 |
Remote Similarity |
NPD7768 |
Phase 2 |
0.6842 |
Remote Similarity |
NPD5844 |
Phase 1 |
0.6839 |
Remote Similarity |
NPD2346 |
Discontinued |
0.6831 |
Remote Similarity |
NPD7610 |
Discontinued |
0.6791 |
Remote Similarity |
NPD1931 |
Clinical (unspecified phase) |
0.6791 |
Remote Similarity |
NPD1930 |
Approved |
0.6791 |
Remote Similarity |
NPD1929 |
Approved |
0.679 |
Remote Similarity |
NPD5808 |
Clinical (unspecified phase) |
0.679 |
Remote Similarity |
NPD6591 |
Clinical (unspecified phase) |
0.6788 |
Remote Similarity |
NPD8443 |
Clinical (unspecified phase) |
0.6783 |
Remote Similarity |
NPD7741 |
Discontinued |
0.6781 |
Remote Similarity |
NPD3972 |
Approved |
0.6776 |
Remote Similarity |
NPD2979 |
Phase 3 |
0.6776 |
Remote Similarity |
NPD7966 |
Clinical (unspecified phase) |
0.6774 |
Remote Similarity |
NPD5408 |
Approved |
0.6774 |
Remote Similarity |
NPD5406 |
Approved |
0.6774 |
Remote Similarity |
NPD5404 |
Approved |
0.6774 |
Remote Similarity |
NPD5405 |
Approved |
0.6766 |
Remote Similarity |
NPD5537 |
Clinical (unspecified phase) |
0.6765 |
Remote Similarity |
NPD7852 |
Clinical (unspecified phase) |
0.6763 |
Remote Similarity |
NPD7993 |
Clinical (unspecified phase) |
0.6753 |
Remote Similarity |
NPD7097 |
Phase 1 |
0.675 |
Remote Similarity |
NPD7422 |
Clinical (unspecified phase) |
0.675 |
Remote Similarity |
NPD7004 |
Clinical (unspecified phase) |
0.6748 |
Remote Similarity |
NPD6599 |
Discontinued |
0.6746 |
Remote Similarity |
NPD6232 |
Discontinued |
0.6731 |
Remote Similarity |
NPD2343 |
Clinical (unspecified phase) |
0.6727 |
Remote Similarity |
NPD7096 |
Clinical (unspecified phase) |
0.6726 |
Remote Similarity |
NPD5494 |
Approved |
0.6711 |
Remote Similarity |
NPD6663 |
Approved |
0.6711 |
Remote Similarity |
NPD7715 |
Approved |
0.6711 |
Remote Similarity |
NPD7714 |
Approved |
0.671 |
Remote Similarity |
NPD2799 |
Discontinued |
0.671 |
Remote Similarity |
NPD7305 |
Phase 1 |
0.6709 |
Remote Similarity |
NPD3750 |
Approved |
0.6707 |
Remote Similarity |
NPD7075 |
Discontinued |
0.6707 |
Remote Similarity |
NPD7411 |
Suspended |
0.6691 |
Remote Similarity |
NPD4141 |
Clinical (unspecified phase) |
0.669 |
Remote Similarity |
NPD5125 |
Phase 3 |
0.669 |
Remote Similarity |
NPD5126 |
Approved |
0.6687 |
Remote Similarity |
NPD5402 |
Approved |
0.6686 |
Remote Similarity |
NPD6959 |
Discontinued |
0.6667 |
Remote Similarity |
NPD6190 |
Approved |
0.6667 |
Remote Similarity |
NPD5736 |
Approved |
0.6667 |
Remote Similarity |
NPD37 |
Approved |
0.6647 |
Remote Similarity |
NPD4965 |
Approved |
0.6647 |
Remote Similarity |
NPD4966 |
Approved |
0.6647 |
Remote Similarity |
NPD4967 |
Phase 2 |
0.6646 |
Remote Similarity |
NPD4380 |
Phase 2 |
0.6645 |
Remote Similarity |
NPD2313 |
Discontinued |
0.6631 |
Remote Similarity |
NPD8319 |
Approved |
0.6631 |
Remote Similarity |
NPD8320 |
Phase 1 |
0.6623 |
Remote Similarity |
NPD6832 |
Phase 2 |
0.662 |
Remote Similarity |
NPD690 |
Clinical (unspecified phase) |
0.6618 |
Remote Similarity |
NPD5909 |
Discontinued |
0.6606 |
Remote Similarity |
NPD6386 |
Approved |
0.6606 |
Remote Similarity |
NPD6385 |
Approved |
0.6604 |
Remote Similarity |
NPD6398 |
Clinical (unspecified phase) |
0.6599 |
Remote Similarity |
NPD1281 |
Approved |
0.6591 |
Remote Similarity |
NPD1989 |
Approved |
0.659 |
Remote Similarity |
NPD7228 |
Approved |
0.6584 |
Remote Similarity |
NPD6143 |
Clinical (unspecified phase) |
0.6579 |
Remote Similarity |
NPD6039 |
Approved |
0.6577 |
Remote Similarity |
NPD5667 |
Approved |
0.6577 |
Remote Similarity |
NPD1876 |
Approved |
0.6576 |
Remote Similarity |
NPD7699 |
Phase 2 |
0.6576 |
Remote Similarity |
NPD7700 |
Phase 2 |
0.6575 |
Remote Similarity |
NPD17 |
Approved |
0.657 |
Remote Similarity |
NPD7997 |
Clinical (unspecified phase) |
0.6568 |
Remote Similarity |
NPD6234 |
Discontinued |
0.6567 |
Remote Similarity |
NPD2066 |
Phase 3 |
0.6566 |
Remote Similarity |
NPD6801 |
Discontinued |
0.6565 |
Remote Similarity |
NPD1202 |
Approved |
0.6564 |
Remote Similarity |
NPD5403 |
Approved |
0.6561 |
Remote Similarity |
NPD2796 |
Approved |
0.6554 |
Remote Similarity |
NPD4878 |
Approved |
0.6552 |
Remote Similarity |
NPD9545 |
Approved |
0.6549 |
Remote Similarity |
NPD4869 |
Clinical (unspecified phase) |
0.6543 |
Remote Similarity |
NPD5401 |
Approved |
0.6541 |
Remote Similarity |
NPD3495 |
Discontinued |
0.6541 |
Remote Similarity |
NPD8285 |
Discontinued |
0.6536 |
Remote Similarity |
NPD6798 |
Discontinued |
0.6534 |
Remote Similarity |
NPD6765 |
Approved |
0.6534 |
Remote Similarity |
NPD6764 |
Approved |
0.6534 |
Remote Similarity |
NPD7685 |
Pre-registration |
0.6533 |
Remote Similarity |
NPD1470 |
Approved |
0.6519 |
Remote Similarity |
NPD7266 |
Discontinued |
0.6516 |
Remote Similarity |
NPD6355 |
Discontinued |
0.6507 |
Remote Similarity |
NPD3025 |
Approved |
0.6507 |
Remote Similarity |
NPD5585 |
Approved |
0.6507 |
Remote Similarity |
NPD3024 |
Approved |
0.6506 |
Remote Similarity |
NPD6873 |
Phase 2 |
0.6503 |
Remote Similarity |
NPD6534 |
Approved |
0.6503 |
Remote Similarity |
NPD6535 |
Approved |
0.6496 |
Remote Similarity |
NPD1237 |
Approved |
0.6494 |
Remote Similarity |
NPD7177 |
Discontinued |
0.6494 |
Remote Similarity |
NPD6233 |
Phase 2 |
0.6494 |
Remote Similarity |
NPD7893 |
Clinical (unspecified phase) |
0.649 |
Remote Similarity |
NPD2798 |
Approved |
0.6489 |
Remote Similarity |
NPD7435 |
Discontinued |
0.6488 |
Remote Similarity |
NPD3817 |
Phase 2 |
0.6481 |
Remote Similarity |
NPD7390 |
Discontinued |
0.6481 |
Remote Similarity |
NPD6799 |
Approved |
0.6477 |
Remote Similarity |
NPD8462 |
Phase 1 |
0.6474 |
Remote Similarity |
NPD6166 |
Phase 2 |
0.6474 |
Remote Similarity |
NPD6168 |
Clinical (unspecified phase) |
0.6474 |
Remote Similarity |
NPD6167 |
Clinical (unspecified phase) |
0.6471 |
Remote Similarity |
NPD7095 |
Approved |
0.6471 |
Remote Similarity |
NPD1932 |
Approved |
0.6467 |
Remote Similarity |
NPD1283 |
Approved |
0.646 |
Remote Similarity |
NPD3887 |
Approved |
0.6457 |
Remote Similarity |
NPD7804 |
Clinical (unspecified phase) |
0.6456 |
Remote Similarity |
NPD2935 |
Discontinued |
0.6456 |
Remote Similarity |
NPD2531 |
Phase 2 |
0.6455 |
Remote Similarity |
NPD7870 |
Phase 2 |
0.6455 |
Remote Similarity |
NPD7871 |
Phase 2 |
0.6443 |
Remote Similarity |
NPD1608 |
Approved |
0.6443 |
Remote Similarity |
NPD6637 |
Approved |
0.6442 |
Remote Similarity |
NPD7410 |
Clinical (unspecified phase) |
0.6441 |
Remote Similarity |
NPD7240 |
Approved |
0.6441 |
Remote Similarity |
NPD6559 |
Discontinued |
0.6439 |
Remote Similarity |
NPD7900 |
Approved |
0.6439 |
Remote Similarity |
NPD7901 |
Clinical (unspecified phase) |
0.6429 |
Remote Similarity |
NPD5761 |
Phase 2 |
0.6429 |
Remote Similarity |
NPD2329 |
Discontinued |
0.6429 |
Remote Similarity |
NPD5760 |
Phase 2 |
0.6423 |
Remote Similarity |
NPD6647 |
Phase 2 |
0.6419 |
Remote Similarity |
NPD3023 |
Approved |
0.6419 |
Remote Similarity |
NPD3026 |
Approved |
0.6412 |
Remote Similarity |
NPD4381 |
Clinical (unspecified phase) |
0.641 |
Remote Similarity |
NPD230 |
Phase 1 |
0.6407 |
Remote Similarity |
NPD6677 |
Suspended |
0.6406 |
Remote Similarity |
NPD8151 |
Discontinued |
0.6405 |
Remote Similarity |
NPD7055 |
Discontinued |
0.6402 |
Remote Similarity |
NPD7698 |
Approved |
0.6402 |
Remote Similarity |
NPD7497 |
Discontinued |
0.6402 |
Remote Similarity |
NPD7696 |
Phase 3 |
0.6402 |
Remote Similarity |
NPD7697 |
Approved |
0.6398
|
Remote Similarity |
NPD4109 |
Clinical (unspecified phase) |